公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
KTD104	通用型免疫（共）沉淀（IP/Co-IP）工具箱（磁珠）	Therapeutic Potential of IL‐37 in Cervical Cancer: Suppression of Tumour Progression and Enhancement of CD47‐Mediated Macrophage Phagocytosis.	3	Molecular Carcinogenesis
KTD104	通用型免疫（共）沉淀（IP/Co-IP）工具箱（磁珠）	SENP1 promotes p27kip1 nuclear export though enhanced SUMOylation in cholangiocarcinoma leading to increased cell proliferation and chemoresistance.	6	International Journal of Molecular Medicine
KTD104	通用型免疫（共）沉淀（IP/Co-IP）工具箱（磁珠）	Neuronal pentraxin 2 in peripheral sensory neurons drives chronic itch through potentiation of the interleukin-31/interleukin-31 receptor pathway in atopic dermatitis	5	Biomol Ther (Seoul)
KTD104	通用型免疫（共）沉淀（IP/Co-IP）工具箱（磁珠）	The role of chemerin in the regulation of cGAS‐STING pathway in gestational diabetes mellitus placenta.		The FASEB Journal
KTD105	通用型免疫（共）沉淀（IP/Co-IP）工具箱（琼脂糖）	Cell culture		Molecular Biology Reports
KTD105	通用型免疫（共）沉淀（IP/Co-IP）工具箱（琼脂糖）	UVB promotes melanogenesis by regulating METTL3	6	Journal of Cellular Physiology
KTD105	通用型免疫（共）沉淀（IP/Co-IP）工具箱（琼脂糖）	Endoplasmic reticulum stress-induced CRELD2 promotes APMAP-mediated activation of TGF-β/SMAD and NF-κB pathways in esophageal squamous cell …	6	Anal Chem
KTD106	通用型免疫印迹（WB）工具箱	Constructing a prognostic risk model for Alzheimer's disease based on ferroptosis	4	Frontiers in Aging Neuroscience
KTD106	通用型免疫印迹（WB）工具箱	Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2	7	Journal of Hospital Infection
KTI1010	通用型免疫（共）沉淀（IP/Co-IP）工具箱（磁珠/抗小鼠）	Co-localization of TAZ and H2A. Z up-regulates IL-6 expression in alveolar epithelial cells to polarize M2 cells to alleviate hypoxia-induced lung injury.	9	Genes & Diseases

首页上一页 509 510 511 512 513 514 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部